IgA antibody / BeOne Medicines, Atreca, IGM Biosciences - LARVOL DELTA

"$IGMS IGM Biosciences to Collaborate on the Study of IgM and IgA Antibodies for the Prevention of Malaria https://t.co/9WAX2tvK3p" (@stock_titan)

Infectious Disease • Malaria

IGM Biosciences Announces First Quarter 2020 Financial Results and Provides Corporate Update (GlobeNewswire, IGM Biosciences) - "Collaboration with Atreca and BeiGene for COVID-19: IGM, Atreca, Inc., and BeiGene, Ltd. announced plans to collaborate to help address the COVID-19 pandemic. The companies will leverage their combined technology and expertise in an effort to discover, develop, and manufacture novel IgM and IgA antibodies targeting SARS-CoV-2 for the potential treatment of COVID-19. If research, manufacturing, and regulatory activities proceed very well, then the companies believe that an antibody may be ready to begin clinical testing in the first half of 2021."

Licensing / partnership • Infectious Disease • Novel Coronavirus Disease